(Press-News.org) Ischemic stroke, a leading cause of disability and mortality worldwide, is a complex cerebrovascular event with outcomes heavily influenced by the inflammatory response. This response, triggered by cerebral ischemia, plays a critically dual role: while exacerbating secondary damage in the acute phase, it is also essential for tissue repair and recovery. The identification and study of inflammation-related biomarkers have thus emerged as a pivotal area of research, offering new avenues for early diagnosis, prognostic assessment, and targeted therapy in the pursuit of precision medicine for stroke.
The Dual-Nature Inflammatory Response Post-Stroke
The inflammatory cascade begins with the release of damage-associated molecular patterns (DAMPs) from dying neurons in the infarct core. These DAMPs activate innate immune pathways, such as Toll-like receptors (TLRs) and the NF-κB signaling pathway, leading to a surge in pro-inflammatory cytokines like IL-1β, TNF-α, and IL-6. This response promotes the infiltration of peripheral immune cells, disrupts the blood-brain barrier (BBB), and amplifies oxidative stress, causing further neuronal death. Conversely, a moderated inflammatory response, driven by anti-inflammatory cytokines like IL-10 and TGF-β, is crucial for facilitating nerve regeneration and angiogenesis, highlighting the need for balanced therapeutic intervention.
Key Inflammatory Biomarkers and Their Mechanisms
The review systematically categorizes and explains the roles of various biomarkers:
Cytokines and Chemokines: IL-6, TNF-α, and IL-1β are key drivers of acute neuroinflammation, with their dynamic levels correlating with stroke severity, infarct volume, and prognosis. The CCL19/CCR7 axis, in particular, has been identified as critical for mediating T cell infiltration into the central nervous system, directly impacting secondary injury.
Acute-Phase Proteins: C-reactive protein (CRP) is a well-established biomarker whose rapid elevation post-stroke assists in diagnosis, differential diagnosis of stroke subtypes, and prognostic evaluation. Other proteins like serum amyloid A and fibrinogen also contribute to the pathophysiology.
Matrix Metalloproteinases (MMPs): MMPs, especially MMP-9, have a time-dependent role. In the acute phase, they contribute to BBB disruption and hemorrhagic transformation. Later, they facilitate tissue remodeling and repair, though excessive activity can be detrimental.
Novel Biomarkers:
MicroRNAs (miRNAs): These small non-coding RNAs exhibit dual functions. For instance, miR-126 protects BBB integrity, while miR-155 exacerbates it. Their rapid changes in serum post-stroke make them promising diagnostic tools and therapeutic targets (e.g., miR-15a/16-1 antagonists).
Galectin-3 (Gal-3): Released by activated microglia, Gal-3 promotes inflammation via the TLR-4/NF-κB pathway. Elevated serum Gal-3 levels are independently associated with poor 90-day outcomes, and its inhibitors are under investigation.
Clinical Applications
Diagnosis: Biomarkers like IL-6, CRP, and MMP-9 rise within hours of stroke onset, aiding early diagnosis. Furthermore, specific inflammatory profiles can help distinguish between stroke subtypes (e.g., atherosclerotic vs. cardioembolic), forming a basis for personalized treatment.
Prognostic Evaluation: Elevated levels of CRP, IL-6, and MMP-9 are consistently correlated with poorer neurological recovery and increased mortality. Ratios such as the neutrophil-to-lymphocyte ratio (NLR) and systemic immune-inflammation index (SII) are powerful, readily available predictors of complications like stroke-associated pneumonia and poor functional outcomes.
Guiding Thrombectomy: Inflammatory biomarkers provide crucial insights for endovascular thrombectomy (EVT). Pre-operative SII and post-operative NLR can predict poor prognosis, while the fibrinogen-to-albumin ratio (FAR) indicates the risk of hemorrhagic transformation. Monitoring CCR7+ T cell frequency may help identify an active neuroinflammatory phase, guiding the timing of intervention to minimize reperfusion injury.
Therapeutic Potential: Inflammatory pathways are promising therapeutic targets. Monoclonal antibodies against IL-1β, MMP inhibitors, and agents that modulate microglial polarization are being explored. The future lies in multi-target combination therapies and using biomarker profiles to guide individualized treatment plans, balancing anti-inflammatory effects with the needs of tissue repair.
Challenges and Future Directions
Despite the promise, significant challenges remain. The complexity and dynamism of inflammation mean single-target interventions may be insufficient. There is a need to balance suppressing harmful inflammation while preserving reparative processes. Future research must focus on standardizing detection methods, validating biomarkers in large-scale trials, developing multi-marker diagnostic and prognostic models, and advancing targeted delivery systems (e.g., using exosomes for miRNA therapy).
Conclusion
The inflammatory response is a cornerstone of ischemic stroke pathophysiology. The comprehensive investigation of inflammatory biomarkers—from classical cytokines to novel miRNAs and Gal-3—provides profound insights for revolutionizing stroke management. These biomarkers are poised to play an increasingly critical role in enabling early diagnosis, accurate prognosis, and the development of precision medicine strategies, ultimately improving patient outcomes.
Full text:
https://xiahepublishing.com/3067-6150/NSSS-2025-00029
The study was recently published in the Neurosurgical Subspecialties.
Neurosurgical Subspecialties (NSSS) is the official scientific journal of the Department of Neurosurgery at Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. NSSS aims to provide a forum for clinicians and scientists in the field, dedicated to publishing high-quality and peer-reviewed original research, reviews, opinions, commentaries, case reports, and letters across all neurosurgical subspecialties. These include but are not limited to traumatic brain injury, spinal and spinal cord neurosurgery, cerebrovascular disease, stereotactic radiosurgery, neuro-oncology, neurocritical care, neurosurgical nursing, neuroendoscopy, pediatric neurosurgery, peripheral neuropathy, and functional neurosurgery.
Follow us on X: @xiahepublishing
Follow us on LinkedIn: Xia & He Publishing Inc.
END
The Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego is expanding its roadway safety education efforts to reach more Californians, with a focus on Native American youth, pedestrian safety and Spanish-speaking communities.
According to the National Highway Traffic Safety Administration (NHTSA), an estimated 39,345 people died in motor vehicle crashes in the United States in 2024, marking one of the highest fatality totals in nearly two decades.
Traffic deaths among American Indian and Alaska Native (AIAN) individuals are 20% higher than the national average, and the gap widens sharply among young ...
NEW YORK CITY and ORLANDO — The American Federation for Aging Research (AFAR) and the McKnight Brain Research Foundation (MBRF) are pleased to announce the 2025 recipients of The McKnight Brain Research Foundation Innovator Awards in Cognitive Aging and Memory Loss: Leah Acker, MD, PhD, Assistant Professor, Duke University, and Erin Gibson, PhD, Assistant Professor, the Stanford School of Medicine.
The Innovator Awards provide funding to research scientists pursuing groundbreaking studies in the field of cognitive aging. Each will receive a three-year award totaling $750,000.
Leah ...
Cervical cancer will be the first human cancer eliminated through coordinated global action. A new special issue of Cancer Biology & Medicine brings together leading experts from around the world to examine progress, challenges, and innovations in prevention, screening, and treatment. From policy frameworks and epidemiological insights to digital health tools and therapeutic vaccines, the collection provides a timely resource for accelerating the World Health Organization’s 2030 targets for cervical cancer elimination and advancing ...
Researchers at Academia Sinica have developed the first population-specific polygenic risk score (PRS) models for people of Han Chinese ancestry, achieving unprecedented accuracy in predicting risks for common diseases such as diabetes, heart disease, autoimmune disorders. The study, published in Nature on October 15,2025, analyzed genomic and health data from more than half a million Taiwanese participants of the Taiwan Precision Medicine Initiative (TPMI) and demonstrates the transformative potential ...
Children who count on their fingers between ages 4 and 6 1/2 have better addition skills by age 7 than those who don’t use their fingers, suggesting that finger counting is an important stepping stone to higher math skills, according to research published by the American Psychological Association.
“Finger counting is not just a tool for immediate success in young children, but a way to support the development of advanced abstract arithmetic skills,” said lead author Catherine Thevenot, PhD, of the University of Lausanne in Switzerland.
Finger counting is widely used by young children as a strategy to solve math problems. However, ...
ROCHESTER, Minn. — Mayo Clinic researchers have developed a new, personalized approach to deep brain stimulation (DBS) for people with drug-resistant epilepsy. By mapping each patient's unique brain wave patterns, the method allows physicians to target the precise area in the brain where stimulation is most effective, moving beyond the traditional one-size-fits-all approach.
DBS involves implanting electrodes in the brain to deliver electrical pulses that help prevent and control seizures. While effective, DBS is typically administered with electrodes placed in the same brain region across most patients. Mayo Clinic physician-scientists ...
Tampa, FL, USA – November 20, 2025 – The Global Virus Network (GVN) is pleased to announce that, for the first time, it is awarding pandemic preparedness research grants, totaling $160,000, to GVN scientists across four continents. These awards support innovative, investigator-led projects designed to enhance viral surveillance, early detection, and scientific preparedness, particularly in regions vulnerable to emerging and re-emerging viral threats.
“These projects represent exactly the kind of targeted, ...
BOSTON — Nov. 20, 2025 — Ginkgo Bioworks (NYSE: DNA) today announced the launch of the Virtual Cell Pharmacology Initiative (VCPI) through Ginkgo Datapoints. This open-source platform is designed to build the first standardized framework for virtual cell modeling in drug discovery by bringing together researchers, pharmaceutical companies and AI developers in a community-driven effort to create the largest public dataset of its kind, aiming to test at least 100,000 compounds and generate >12 billion data points.
Virtual cells, AI-powered digital representations of biological cells, are emerging as a critical ...
CLEVELAND—About 360 million years ago, the shallow sea above present-day Cleveland was home to a fearsome apex predator: Dunkleosteus terrelli. This 14-foot armored fish ruled the Late Devonian seas with razor-sharp bone blades instead of teeth, making it among the largest and most ferocious arthrodires—an extinct group of shark-like fishes covered in bony armor across their head and torso.
Since its discovery in the 1860s, Dunkleosteus has captivated scientists and the public alike, becoming ...
MINNEAPOLIS / ST. PAUL (11/20/2025) — A team of organic and computational chemists at the University of Minnesota Twin Cities have created a new, modern tool to make the process of creating pharmaceuticals and agrochemicals faster, cost-effective, and energy-efficient.
The research, recently published in Nature, details a new method for creating the essential starting materials, known as precursors, used in chemical reactions. A patent is pending for this technique.
Chemists use what are called “aryne intermediates” as building blocks to make complex molecules more efficiently in areas such as pharmaceuticals ...
